Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Copenhagen

768 clinical trials in Copenhagen, Denmark across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Copenhagen at a glance
768
clinical trials
  • Research sites8
Type of trial
Recruitment status
Quick filters

768 trials in Copenhagen

Open in trial search

Asthma

Recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Enfortumab Vedotin
  • Sponsor:Eli Lilly & Co.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Empasiprubart
  • Sponsor:Argenx

Psoriasis

Recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Darovasertib
  • Sponsor:Ideaya Biosciences Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.

Other cities in Denmark

The busiest research cities in the country

All 47 cities in Denmark

Clinical research in Copenhagen

What the registry says about research in the country

01 Respiratory & Pulmonary Studies

Clinical research focusing on chronic obstructive pulmonary disease (COPD) and nasal conditions, evaluating new therapeutic approaches for respiratory disorders.

  • COPD Treatment Evaluation
  • Chronic Rhinosinusitis Management
  • Nasal Polyps Research

Studies aim to improve treatment outcomes and quality of life for patients with respiratory conditions.

02 Metabolic & Endocrine Research

Investigations into early-onset obesity and related metabolic disorders, with emphasis on innovative treatment approaches.

  • Obesity Management
  • Metabolic Disease Treatments
  • Clinical Weight Management

Focus on developing effective interventions for weight-related health conditions.

03 Mental Health Studies

Research addressing postpartum depression and psychiatric disorders, including innovative hormone therapy approaches and sleep disorders.

  • Maternal Mental Health
  • Insomnia Treatment
  • Depression Prevention

Emphasis on developing targeted treatments for specific mental health conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).